Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS – Sarepta Therapeutics

  1. Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS  Sarepta Therapeutics
  2. Updated: Sarepta would have to conduct new studies to get back on market, FDA official says  Endpoints News
  3. Third death from a Sarepta gene therapy  biocentury.com
  4. This Week’s CGT News: Partnership to Boost Australian CGT Landscape  The Medicine Maker
  5. For many Duchenne families, halt to gene therapy is heartbreak upon heartbreak  statnews.com

Continue Reading